Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Poul will take over the company in January after spending 11 years with 3M and working at Medtronic and Boston Scientific.

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

Hologic has recalled the Biozorb devices after 188 reports of adverse events in patients who received the implants in breast ...

Study author Philippe Genereux said the trial data “shatter 60 years of ingrained belief on the treatment for severe aortic ...